RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035232.xml
PDF herunterladen
Der Schmerzpatient 2020; 3(04): 155-156
DOI: 10.1055/a-1265-4515
DOI: 10.1055/a-1265-4515
Gelesen und kommentiert
‚Explain Pain‘ vs. Placebo-Edukation
Authors
Zusammenfassung der Studie
Hintergrund
Angesichts der gängigen nicht leitlinienkonformen Versorgung von Kreuzschmerzpatienten mit erhöhtem Chronifizierungsrisiko ist eine Strategie zur Früherkennung und edukativen Behandlung dieser Patientengruppe dringend erforderlich.
Scroll to top
Publikationsverlauf
Artikel online veröffentlicht:
21. Oktober 2020
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Butler D, Moseley L. Explain Pain. Adelaide: Noigroup Publication; 2003
- 2 Nijs J, van Wilgen PC, Van Oosterwijck J. et al. How to explain central sensitization to patients with ‘unexplained’ chronic musculoskeletal pain: Practice guidelines. Manual Therapy 2011; 16 (05) 413-418 doi:10.1016/j.math.2011.04.005
- 3 Louw A, Schmidt S, Puentedura EJ. et al. Pain Neuroscience Education: Teaching People About Pain. Minneapolis: Orthopedic Physica Therapy Products; 2018
- 4 Engers A, Jellema P, Wensing M. et al. Individual patient education for low back pain. Cochrane Database Syst Rev 2008; (01) CD004057
- 5 Louw A, Zimney K, Puentedura EJ. et al. The efficacy of pain neuroscience education on musculoskeletal pain: A systematic review of the literature. Physiother Theory Pract 2016; 32 (05) 332-355 doi:10.1080/09593985.2016.1194646
- 6 Tegner H, Frederiksen P, Esbensen BA. et al. Neurophysiological Pain-education for Patients with Chronic Low Back Pain – A Systematic Review and Meta-analysis. Clin J Pain 2018; 34 (08) 778-786 doi:10.1097/AJP.0000000000000594
- 7 Louw A, Puentedura EJ, Diener I. et al. Pain neuroscience education: Which pain neuroscience education metaphor worked best?. S Afr J Physiother 2019; 75 (01) 1329 doi:10.4102/sajp.v75i1.1329
- 8 Rossettini G, Carlino E, Testa M. Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain. BMC Musculoskeletal Disorders 2018; 19 (27) 1-15 doi:10.1186/s12891-018-1943-8
- 9 Testa M, Rossettini G. Enhance placebo, avoid nocebo: How contextual factors affect physiotherapy outcomes. Manual Therapy 2016; 24: 65-74 doi:10.1016/j.math.2016.04.006
- 10 Whiteside N, Sarmanova A, Chen X. et al. Proportion of contextual effects in the treatment of fibromyalgia – a meta-analysis of randomised controlled trials. Clin Rheumatol 2018; 37 (05) 1375-1382 doi:10.1007/s10067-017-3948-3
- 11 Zou K, Wong J, Abdullah N. et al. Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials. Annals of the Rheumatic Diseases 2016; 75: 1964-1970 doi:10.1136/annrheumdis-2015-208387
- 12 Karran EL, McAuley JH, Traeger AC. et al. Can screening instruments accurately determine poor outcome risk in adults with recent onset low back pain? A systematic review and meta-analysis. BMC Medicine 2017; 15: 13 doi:10.1186/s12916-016-0774-413
- 13 Traeger AC, Henschke N, Hübscher M. et al. Estimating the Risk of Chronic Pain: Development and Validation of a Prognostic Model (PICKUP) for Patients with Acute Low Back Pain. PLoS Med 2016; 13 (05) e1002019 doi:10.1371/journal.pmed.1002019